Apolipoprotein L, 1 (APOL1) ELISA Kits

APOL1 encodes a secreted high density lipoprotein which binds to apolipoprotein A-I. Zusätzlich bieten wir Ihnen APOL1 Antikörper (136) und APOL1 Proteine (5) und viele weitere Produktgruppen zu diesem Protein an.

list all ELISA KIts Gen GeneID UniProt
APOL1 8542 O14791
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top APOL1 ELISA Kits auf antikoerper-online.de

Showing 10 out of 19 products:

Katalog Nr. Reaktivität Sensitivität Bereich Bilder Menge Lieferzeit Preis Details
Human 0.51 ng/mL 1.25 ng/mL - 80 ng/mL 96 Tests 13 bis 16 Tage
Ratte 7.1 pg/mL 15.6 pg/mL - 1000 pg/mL 96 Tests 13 bis 16 Tage
Kaninchen 0.1 ng/mL 2.5-50 ng/mL   96 Tests 15 bis 18 Tage
Meerschweinchen 0.1 ng/mL 2.5-50 ng/mL   96 Tests 15 bis 18 Tage
Maus 0.1 ng/mL 2.5-50 ng/mL   96 Tests 15 bis 18 Tage
Affe 0.1 ng/mL 2.5-50 ng/mL   96 Tests 15 bis 18 Tage
Hund 0.1 ng/mL 2.5-50 ng/mL   96 Tests 15 bis 18 Tage
  96 Tests 15 bis 18 Tage
  96 Tests 15 bis 18 Tage
  96 Tests 15 bis 18 Tage

Am meisten referenzierte APOL1 ELISA Kits

  1. Human APOL1 ELISA Kit für Sandwich ELISA - ABIN419395 : Van Vinh Chau, Buu Chau, Desquesnes, Herder, Phu Huong Lan, Campbell, Van Cuong, Yimming, Chalermwong, Jittapalapong, Ramon Franco, Tri Tue, Rabaa, Carrique-Mas, Pham Thi Thanh, Tran Vu Thieu, Berto et al.: A Clinical and Epidemiological Investigation of the First Reported Human Infection With the Zoonotic Parasite Trypanosoma evansi in Southeast Asia. ... in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016 (PubMed)

Weitere ELISA Kits für APOL1 Interaktionspartner

Human Apolipoprotein L, 1 (APOL1) Interaktionspartner

  1. lacking APOL1 renal-risk genotypes, JC polyomavirus was detected in 12.2% of cases and 48.8% of controls

  2. Status as a carrier of a high-risk APOL1 genotype was associated with HFpEF hospitalization among postmenopausal women, which is partly accounted for by baseline kidney function. These findings do not support an association of high-risk APOL1 genotypes with coronary heart disease, stroke, or mortality in postmenopausal African American women.

  3. data showing no cytotoxicity of overexpressed APOL1 isoform lacking exon 4, we propose that morpholino-induced APOL1 isoform switch may provide a new tool to identify in vivo molecular mechanism(s) by which risk alleles promote or mediate the kidney disease phenotype.

  4. Our results indicate that APOL1-mediated pore formation is critical for the trypanolytic activity of APOL1 and drives APOL1-mediated cytotoxicity in overexpression systems.

  5. There are striking differences in chronic kidney disease between Caucasians and African descendants. It was widely accepted that this occurred due to socioeconomic factors, but recent studies show that apolipoprotein L-1 (APOL1) gene variants are strongly associated with focal segmental glomerulosclerosis, HIV-associated nephropathy, hypertensive nephrosclerosis, and lupus nephritis in the African American population

  6. Modulation of the APOL1-miR193a axis carries a potential to preserve podocyte molecular phenotype in high glucose milieu.

  7. APOL1 renal-risk variant protein has a role in the development of nephropathy; this is true in both native kidney disease and after renal transplantation [review]

  8. APOL1 high-risk status is associated with CVD events in community-dwelling Black adults without diabetes mellitus.

  9. ApoL1 variants regulate monocyte differentiation into macrophages and eicosanoid metabolism via enhanced COX-2 expression.

  10. Among blacks without baseline CVD, the APOL1 high-risk variants may be associated with increased risk for incident heart failure but not subclinical CVD or incident clinical atherosclerotic CVD.

  11. Donor APOL1 high-risk genotypes are associated with inferior graft survival and de novo collapsing focal segmental glomerulosclerosis with high proteinuria after kidney transplantation.

  12. Individual genome-wide association studies and meta-analysis results of 2650 end-stage renal disease (ESRD) cases and 1656 controls African American patients did not detect significant genome-wide associations with ESRD beyond APOL1. Similarly, no single nucleotide polymorphism showed significant genome-wide evidence of an interaction with APOL1 risk variants. [meta-analysis]

  13. Fetal APOL1 high-risk genotype increases the risk for preeclampsia, likely by adversely affecting placental function.

  14. These studies establish APOL1 as a bona fide LD-associated protein, and reveal that recruitment of risk variant APOL1 to LDs reduces cell toxicity, autophagic flux, and cell death.

  15. APOL1 genotype may not be sufficient to explain discrepancies in postdonation kidney function between caucasian donors and low-risk APOL1 genotype living kidney donors of African ancestry.

  16. APOL1 risk variants contribute to podocyte injury through enhanced endoplasmic reticulum stress. The study provides insight into new mechanisms involved in APOL1 risk variants-induced podocyte damage, and highlights some new therapeutic targets for APOL1-associated nephropathy.

  17. Apolipoprotein L1 risk variants are present in black South Africans with similar frequencies between chronic kidney disease patients, first-degree relatives, and healthy controls.

  18. Plasma concentrations of TNFR1, TNFR2, and KIM1 are independently associated with renal outcome and improve discrimination or reclassification of African ancestry individuals with a high-risk APOL1 genotype and preserve renal function.

  19. APOL1 risk variants did not associate with subclinical markers of atherosclerosis or left ventricular hypertrophy in middle-aged black adults with preserved kidney function.

  20. Review of the role of APOL1 in kidney disease in children and young adults of African ancestry. APOL1 explains almost 70% of the excess risk of kidney disease in those of African descent, and is common in children with glomerular disease.

Zebrafish Apolipoprotein L, 1 (APOL1) Interaktionspartner

  1. zApoL1 is essential for proper blood filtration in the zebrafish glomerulus and that zApoL1 affects the expression of nephrin

APOL1 Antigen-Profil

Beschreibung des Gens

This gene encodes a secreted high density lipoprotein which binds to apolipoprotein A-I. Apolipoprotein A-I is a relatively abundant plasma protein and is the major apoprotein of HDL. It is involved in the formation of most cholesteryl esters in plasma and also promotes efflux of cholesterol from cells. This apolipoprotein L family member may play a role in lipid exchange and transport throughout the body, as well as in reverse cholesterol transport from peripheral cells to the liver. Several different transcript variants encoding different isoforms have been found for this gene.

Genbezeichner und Symbole assoziert mit Apolipoprotein L, 1 (APOL1) ELISA Kits

  • apolipoprotein L1 (APOL1) Antikörper
  • apolipoprotein L, 1 (apol1) Antikörper
  • APO-L Antikörper
  • APOL Antikörper
  • APOL-I Antikörper
  • FSGS4 Antikörper
  • si:rp71-1g18.12 Antikörper
  • wu:fa95b12 Antikörper
  • wu:fc30h04 Antikörper

Bezeichner auf Proteinebene für Apolipoprotein L, 1 (APOL1) ELISA Kits

apolipoprotein L1

8542 Homo sapiens
560340 Danio rerio
Ausgewählte Anbieter für APOL1 (APOL1) ELISA Kits
Haben Sie etwas anderes gesucht?